Tert-butyl N-[1-(8-bromo-4,5-dihydro-3H-[1]benzoxepino[4,5-d]imidazol-2-yl)cyclobutyl]carbamate
C20H24BrN3O3 — CID 123823046
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[1-(8-bromo-4,5-dihydro-3H-[1]benzoxepino[4,5-d]imidazol-2-yl)cyclobutyl]carbamate
Tert-butyl N-[1-(8-bromo-4,5-dihydro-3H-[1]benzoxepino[4,5-d]imidazol-2-yl)cyclobutyl]carbamate (PubChem CID 123823046) has the molecular formula C20H24BrN3O3 and a molecular weight of 434.33 g/mol. Its IUPAC name is tert-butyl N-[1-(8-bromo-4,5-dihydro-3H-[1]benzoxepino[4,5-d]imidazol-2-yl)cyclobutyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[1-(8-bromo-4,5-dihydro-3H-[1]benzoxepino[4,5-d]imidazol-2-yl)cyclobutyl]carbamate |
|---|---|
| PubChem CID | 123823046 |
| Molecular Formula | C20H24BrN3O3 |
| Molecular Weight | 434.33 g/mol |
| Exact Mass | 433.10 |
| IUPAC Name | tert-butyl N-[1-(8-bromo-4,5-dihydro-3H-[1]benzoxepino[4,5-d]imidazol-2-yl)cyclobutyl]carbamate |
| SMILES | CC(C)(C)OC(=O)NC1(c2nc3c([nH]2)CCOc2cc(Br)ccc2-3)CCC1 |
| InChI | InChI=1S/C20H24BrN3O3/c1-19(2,3)27-18(25)24-20(8-4-9-20)17-22-14-7-10-26-15-11-12(21)5-6-13(15)16(14)23-17/h5-6,11H,4,7-10H2,1-3H3,(H,22,23)(H,24,25) |
| InChIKey | RUSADRICLQZOTP-UHFFFAOYSA-N |
| XLogP | 4.68 |
| TPSA | 76.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.33 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123823046 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.